rdf:type |
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0010186,
umls-concept:C0011108,
umls-concept:C0020538,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0205344,
umls-concept:C0220812,
umls-concept:C0679006,
umls-concept:C1292734,
umls-concept:C1522326
|
pubmed:issue |
9
|
pubmed:dateCreated |
2003-8-18
|
pubmed:abstractText |
To estimate the effectiveness and cost-effectiveness of blood pressure-lowering treatment over a lifetime.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0263-6352
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1753-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12923409-Adult,
pubmed-meshheading:12923409-Aged,
pubmed-meshheading:12923409-Antihypertensive Agents,
pubmed-meshheading:12923409-Cost-Benefit Analysis,
pubmed-meshheading:12923409-Decision Making,
pubmed-meshheading:12923409-Drug Costs,
pubmed-meshheading:12923409-Female,
pubmed-meshheading:12923409-Great Britain,
pubmed-meshheading:12923409-Health Care Costs,
pubmed-meshheading:12923409-Humans,
pubmed-meshheading:12923409-Hypertension,
pubmed-meshheading:12923409-Life Expectancy,
pubmed-meshheading:12923409-Male,
pubmed-meshheading:12923409-Markov Chains,
pubmed-meshheading:12923409-Middle Aged,
pubmed-meshheading:12923409-Models, Statistical,
pubmed-meshheading:12923409-Quality-Adjusted Life Years,
pubmed-meshheading:12923409-Risk Factors,
pubmed-meshheading:12923409-Sensitivity and Specificity
|
pubmed:year |
2003
|
pubmed:articleTitle |
The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.
|
pubmed:affiliation |
Division of Primary Health Care, University of Bristol, UK. alan.a.montgomery@bristol.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|